Dr. Deepak Kamnasaran, CEO, president, and founder of CEN4GEN tells us about genetic tests and diagnostics.
First of all, how are you and your family doing in these COVID-19 times?
Dr. Deepak Kamnasaran: Thank you for asking. We are fine thanks. I hope you and your family are doing well too.
Tell us about you, your career, and how you founded CEN4GEN.
Dr. Deepak Kamnasaran: I am a Medical Geneticist, Technology innovator, and Educator from Canada. My life has been inspired by my parents: Dr. Kam Kamnasaran and Mrs. Madodareedevi Kamnasaran; both of whom are educators and who have helped and mentored thousands of people throughout their careers. I was a former Academic Faculty in Pediatrics (Canada), and Medical Scientist (Canada) for several years. Thus far, I have made several hundred contributions as an Author in reputable journals, book chapters, encyclopedias, global lectureships, global scientific meeting organizer, academic journal reviewer and editorial board, global mentorships, grant reviewer and as a scientific judge, to name a few. I have also won numerous prestigious global awards, including several Young Investigator awards from the American Association of Indian Scientists in Cancer Research, Canadian Brain Tumor Foundation, Canadian Society of Neuro-oncology, American Society of Neuro-oncology, Pediatric Brain Tumor Foundation (USA); as well as other awards such as from the American Association of Cancer Research, European Cancer meeting (UK) and Cold Spring Harbour Laboratory (USA), to mention a few.
With my expertise in biomedical sciences, I founded CEN4GEN Institute for Genomics and Molecular diagnostics in 2014 with a mission to provide comprehensive and cutting edge services and products to individuals, healthcare practitioners, and researchers worldwide by using state of the art and current technologies, strategies, scientific and medical knowledge involving genome medicine and applied genomics.
Thus far, CEN4GEN is proud to serve clients from Canada, as well as five continents. Our clients are from hospitals, universities, clinics, commercial entities, and private individuals. Furthermore, CEN4GEN is honored for being spotlighted or cited in many publications and the media. CEN4GEN is an award-winning company and is frequently nominated for prestigious awards.
How does CEN4GEN innovate?
Dr. Deepak Kamnasaran: Since its inception, the organization of CEN4GEN is comprised of expert personnel who use the most recent cutting-edge technologies, strategies, and knowledge in the services and products we provide. Therefore, we innovate by ensuring that we have assembled a profound team of expert personnel with the correct technologies that can adapt rapidly to the evolving needs of what our clients require from us. We strive to be abreast with the most recent biomedical knowledge and technologies.
How the coronavirus pandemic affects your business and how are you coping?
Dr. Deepak Kamnasaran: The pandemic has certainly imposed challenges to businesses globally, including CEN4GEN. During this period, CEN4GEN took the notion to evaluate our operational framework to maximize efficiency. We pursued this period to innovate and explore other avenues of products and services which we think could help in the advancement of global healthcare, as well as to ease the pandemic crisis. For instance, during this period, the organization of CEN4GEN has:
- developed COVID19 detection and screening products;
- developed COVID19 vaccine efficacy detection products;
- developed COVID19 genetic susceptibility tests;
- manufactured a wide spectrum of personal protective equipment/clothing items that are applicable to a wide range of work sectors.
Did you have to make difficult choices and what are the lessons learned?
Dr. Deepak Kamnasaran: Certainly difficult choices had to be made. However, under these pandemic times, CEN4GEN has learned how to clearly identify the challenges, what CEN4GEN can do under the current circumstance to survive those challenges, and most importantly how CEN4GEN can contribute towards helping to alleviate the pandemic crisis using genome medicine strategies and to manufacture personal protective equipment. We have learned that it was important to diversify our infrastructure of services and products that we offer to adapt to the pandemic crisis.
What specific tools, software, and management skills are you using to navigate this crisis?
Dr. Deepak Kamnasaran: The current infrastructure of CEN4GEN is quite robust and flexible to handle a wide spectrum of challenges. We have utilized our existing SOP guidelines, together with the SWOT, PESTLE, and MOST business analysis methods to help alleviate some of the challenges experienced, to innovate during the crisis, and to assist in easing the pandemic crisis.
Who are your competitors? And how do you plan to stay in the game?
Dr. Deepak Kamnasaran: Although there are competitors who have overlapping missions as CEN4GEN, CEN4GEN’s philosophy is working towards a more collegial manner with people and other business entities, including our competitors. There are always various types of skills, etc that competitors could offer your company and vice versa in a collegial manner. We are always open to collaborations and partnerships with individuals as well as private and public sector entities that share a common interest with CEN4GEN and can contribute to CEN4GEN’s long-term mission.
Your final thoughts?
Dr. Deepak Kamnasaran: I am very fortunate to be well accomplished throughout my life this far. My advice to anyone who wants to venture into the business sector is to do something that you are truly passionate about; you should have knowledge and expertise within the field of your business objectives; be creative and work hard to fulfill your dreams. The organization of CEN4GEN always welcomes collaborations and partnerships with individuals, teams, and entities (private and public sectors), including both new and experienced entrepreneurs.